Mary-Ellen Taplin.

Research Participants The analysis was conducted at 156 sites in 15 countries. Patients were eligible for enrollment if they experienced a histologically or cytologically confirmed analysis of prostate cancer, castrate degrees of testosterone , previous treatment with docetaxel, and progressive disease defined according to PCWG2 criteria , including three increasing values for prostate-particular antigen or radiographically confirmed progression with or without a rise in the PSA level.14 A complete set of exclusion and inclusion requirements is provided in the protocol.Kaiser Health News, an editorially independent information service, is an application of the Kaiser Family Foundation, a nonpartisan healthcare policy research firm unaffiliated with Kaiser Permanente.

Actavis receives final FDA acceptance for Zolpidem ER Tablets Actavis, an international generic pharmaceuticals organization, today announced that it has received final approval from the united states Food & Drug Administration to market Zolpidem Tartrate Extended-Discharge Tablets USP, 12.5 mg CIV.5 mg enables Actavis to offer both strengths to meet up the requirements of our customers.’.

AARP launches advertising campaign for health care reform AARP’s national CEO William Novelli was joined by Governor Arnold Schwarzenegger today at the Pasadena Convention Middle for the to begin a series of AARP forums on California healthcare reform.